Bahr, Julian C <br/><br/>
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras.  [electronic resource] 

 -  Oncotarget  Oct 2016 
 - 69804-69815 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.12001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Depsipeptides--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Genes, ras<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Mutation<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Signal Transduction--drug effects